Adrian Dubock, Ph.D.
Dr. Dubock is a member of the Advisory Board of the Freiburg Institute of Advanced Studies, School of Life Sciences and School of Soft Matter Research, Albert-Ludwigs-Universität, Freiburg, Germany. Formerly a senior executive of Syngenta responsible for Mergers, Acquisitions, Ventures and Intellectual Property Licensing, he is currently the Executive Secretary of the Golden Rice Humanitarian Board, and also Golden Rice Project Manager.
Dr. Dubock reports no commercial conflicts of interest.
Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.
Estimated course time: 1 hour(s).
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®, you should be able to:
Describe how a genetically modified crop differs from a conventionally bred crop
Describe the benefits of biofortification compared to fortification or supplementation as exemplified by Golden Rice
Discuss the scientific evidence for more or less caution with respect to genetically modified crops.